All News

Although the new coronavirus has led to a delay in some cholangiocarcinoma trials, experts don’t expect the trials to come to an end.

COVID-19 has forced many people into a “new normal” that they aren’t familiar with and may not be equipped to handle. But cancer survivors are more prepared than most to handle the ramifications of the pandemic.

A cancer survivor describes the comparison between coping with cancer and COVID-19. Much of it is the same.

Patients who recently had lung cancer surgery are not at a higher risk for getting the new coronavirus unless they are routinely coming in and out of the hospital, according to one expert.

Immunotherapy and targeted therapy medications have brought new hope to patients with advanced disease.

The COVID-19 Pandemic has drastically altered the landscape for both oncology professionals and patients with cancer. For oncology nurse Patricia Jakel, the pandemic has altered both her professional and personal lives as an oncology professional and patient.

Cancer treatment has taught many survivors how to combat infection, a useful skill to adjusting life amid the COVID-19 pandemic.

After failing to meet its primary endpoint of progression-free survival, the JAVELIN Ovarian PARP 100 clinical trial was stopped.

The COVID-19 pandemic has forced many to shelter in place causing a rare form of isolation. One that has even challenged a group of people used to challenges, patients with cancer and survivors.

COVID-19 care may show a familiar roadmap to cancer care that some patients and caregivers wish they had.

The Food and Drug Administration approved Koselugo to treat pediatric patients aged 2 years or older with neurofibromatosis type 1, a rare genetic disorder that causes tumors to grow on nerves.

The COVID-19 pandemic has cut out many face-to-face interactions, and for patients with cancer that can also mean a loss of connection to expert advice. But the team behind the Belong.Life app is looking to bridge the gap patients face during social distancing.

Spring is still here, and the warmer weather can help you handle your cancer and COVID-19 related anxieties.

From legendary singer-songwriter John Prine passing away due to coronavirus complications to one patient’s doctor seeing her through her scan when her family couldn’t be there due to COVID-19 restrictions, here’s what is making the headlines in the cancer space this week.

Using immunotherapy earlier, immediately after the conclusion of chemotherapy to treat metastatic bladder cancer, can delay the time until disease progression.

Going in for an infusion amid the coronavirus pandemic with a possible "symptom" of COVID-19 and wondering what risks lie ahead.

The Food and Drug Administration approved the combination use of Braftovi plus Erbitux for the treatment of adult patients with metastatic colorectal cancer with a BRAF V600E mutation.

A guy with breast cancer has a simple suggestion for coping with stress.

Bruton tyrosine kinase (BTK) inhibitors and other new drugs are improving outcomes for patients with CLL.

Regardless of breastfeeding duration, women who did so after giving birth had a lower risk of developing ovarian cancer, including high-grade tumors.

The Food and Drug Administration approved the dual immunotherapy of Opdivo and Yervoy for the treatment of patients with advanced hepatocellular carcinoma. Here’s what you need to know.

For once, I'm noticing a new role of cancer in my life as the survival skills I've picked up are helping me persevere through a global pandemic.

The COVID-19 pandemic has created a unique challenge for patients with myelodysplastic syndromes and acute myeloid leukemia, creating many questions that experts tried to answer in a recent webinar from The Aplastic Anemia and MDS International Foundation.

Patients with mantle cell lymphoma who were eligible for stem cell transplant saw a 97% overall response rate to a three-drug regimen, according to findings from two clinical trials.

If you or someone in your home does contract coronavirus, your doctor may suspend or delay your cancer treatments to protect your immune system, an expert from Tampa Bay Radiation Oncology notes.

The COVID-19 pandemic has brought a number of new challenges to patients with cancer, and one of them is reliving the isolation and anxiety that cancer brings.

At one-year follow-up, phase 2 clinical trial results showed that most patients with relapsed or treatment resistant mantle cell lymphoma responded to chimeric antigen receptor (CAR)-T cell therapy.